Detalles de la búsqueda
1.
17DD Yellow Fever Revaccination and Heightened Long-Term Immunity in Populations of Disease-Endemic Areas, Brazil.
Emerg Infect Dis;
25(8): 1511-1521, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31298654
2.
Comprehensive landscape of neutralizing antibody and cell-mediated response elicited by the 1/5 fractional dose of 17DD-YF primary vaccination in adults.
Sci Rep;
14(1): 7709, 2024 04 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38565882
3.
Exploratory study of humoral and cellular immunity to 17DD Yellow Fever vaccination in children and adults residents of areas without circulation of Yellow Fever Virus.
Vaccine;
40(5): 798-810, 2022 01 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-34969545
4.
Corrigendum: Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever Vaccine.
Front Immunol;
10: 2433, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31695694
5.
Short-Lived Immunity After 17DD Yellow Fever Single Dose Indicates That Booster Vaccination May Be Required to Guarantee Protective Immunity in Children.
Front Immunol;
10: 2192, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31616412
6.
Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever Vaccine.
Front Immunol;
10: 1211, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31293563
Resultados
1 -
6
de 6
1
Próxima >
>>